History

2018

2017

2016

2015

2014

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2018

December

Yinyi/Yinyi intravascular stent and Qingzhou/Bingo intravascular catheter were rated as Dalian Famous Brand Products.

December 5th

Yinyi Biopharmaceutical Elution Balloon Catheter (Registration Certificate No.: National Machinery Note 20173771535) was selected into the "Innovative Medical Device Product Catalog (2018)" of the Ministry of Science and Technology.

September 20th

The company was invited to attend the 2018 12th China Consumer Economy High-level Forum and China Pharmaceutical Industry Future Development Summit, and was awarded the China Medical Device Quality Award.

October

The company was appraised by the Liaoning Provincial Industry and Information Commission as a "Professional, Specialized, New" Enterprise in 2018.

October 31st

The company's self-developed and innovative product, drug eluting balloon catheter, was appraised by the Liaoning Provincial Industry and Information Committee as the "Specialized, Special-New" product technology in 2018.

August

The company passed the high-tech enterprise certification again.

May 10th

The company participated in the first China Independent Brand Expo and China Brand Development International Forum held in Shanghai. As an exhibitor in the Dalian region, Yinyi Bio will showcase the world's first drug balloon for coronary bifurcation lesions and the world's first carrier-free microblind heart stent.

April 27th

The company completed the industrial and commercial change registration procedures for increasing the registered capital and obtained the new business license after the change. After this change, the company's registered capital increased from RMB 128,088,900 to RMB 137,014,552.

March 22

From March 22nd to March 25th, the 16th China Interventional Cardiology Conference (CIT2019). During the conference, the company held a "Qingzhou" drug balloon bifurcation treatment forum. The forum invites many well-known experts in the field of coronary intervention to discuss the latest clinical progress of drug balloons, share wonderful cases of bifurcation lesions treated with drug balloons, and look forward to the future development of interventional therapy.

February

The National Development and Reform Commission, Dalian Development and Reform Commission, and Jinpu New District Economic Development Bureau have successively approved the establishment of a national and local joint engineering research center for biomedical materials research and development technology.

January 20th

During the Interventional Salon of Jiuhua Villa in Beijing, a national launch meeting for the "Qingzhou Drug Eluting Balloon Catheter" was held.

January 10th

In Dalian Conrad Hotel, a press conference for the launch of "Qingzhou Drug Eluting Balloon Catheter" was held and the first batch of strategic cooperation signing ceremony was held.

2017

April 30th

Wabei New Third Board Research Institute released "April 2017, Liaoning New Third Board Enterprise Market Value TOP100, Yinyi Biology ranked 12th.

January 19th

Wabei New Third Board Research Institute released the "2016 New Third Board Top 100 Most Innovative Enterprises" list, and Yinyi Biology ranked 41st.

2016

December 18th

Yinyi Biotech held the 2016 annual management review meeting in the company's headquarters.

December 16th

Yinyi Biological held the 2016 fire drill and escape drill at the company headquarters.

December 2nd-3rd

Yinyi Biology sent staff to participate in the 13th Dalian International Symposium on New Advances in Diagnosis and Treatment of Coronary Heart Disease in Dalian.

October 31st

Yinyi Biotechnology completed all the follow-up work of the Qingzhou drug balloon clinical trial (bifurcation lesion project).

October 23rd

Yinyi Biotech sent staff to participate in the second council of the third session of the surgical implant professional committee of China Medical Device Industry Association in Beijing.

October 14-16

The State Food and Drug Administration conducted an "flying inspection" on the implementation of Yinyi Biotech's "Medical Device Manufacturing Quality Management Regulations".

September 20th

The authoritative list of China's NEEQ innovative brands, co-sponsored by AsiaBrand.com and Xinhuanet.com, was announced, and Yinyi Bio was ranked 80th.

September 12th

Yinyi Biology sent staff to participate in the "2016 New Third Edition Top 100 Brands" conference held in Beijing.

September 10th

The China-Israel Foundation and the Israeli delegation visited the Yinyi Biological Headquarters and the International Innovation Industrial Park for Class III Medical Devices in Double D Port.

September 9th

The Israel Innovation Investment Conference hosted by Yinyi Biotechnology was held at Dalian Xinghai Expo Exhibition Center.

August 6th

The provisional board of directors of Yinyi Biology was held in Dalian headquarters.

August 3rd

Liaoning Provincial Pharmaceutical Certification Center conducted an on-site investigation on the implementation of the inspection work of Yinyi's biomedical device registration system.

July 29-30th

Yinyi Biotech held a semi-annual meeting of sales managers in Dalian headquarters.

July 7-8th

The Liaoning Provincial Pharmaceutical Certification Center has conducted a new product registration system inspection on Yinyi Biologics "Contrast Catheter" in accordance with the "Medical Device Manufacturing Quality Management Regulations".

June 5th

The "2016 Liaoning New Third Board Listed Enterprises Top 100 Total Assets Ranking" released by the China Business Industry Research Institute, Yinyi Biology ranked 22nd.

June 12-14

Liaoning Provincial Food and Drug Administration conducts on-site supervision and inspection of Yinyi biological production quality management.

May 26-29th

Yinyi Biotech participated in the "Eleventh Oriental Cardiology Conference" held at the Shanghai World Expo Center.

May

The "contrast catheter" independently researched and developed by Yinyi Biotechnology is submitted to the national new product registration.

April 25th

Beijing National Medical Equipment Huaguang Certification Co., Ltd. conducts annual supervision and review of the quality management system of Yinyi Biological.

April 22-24

Yinyi Biology participated in the "Nineteenth National Interventional Heart Disease Forum" held in Shijiazhuang, Hebei.

April 15th

Yinyi Bio-Bio held its 2015 annual sales meeting in Dalian headquarters.

April 7-10

Yinyi Bio will participate in the "18th Southern International Cardiovascular Conference".

April

Yinyi Biopharmaceuticals completed the first financing of 6512204 million yuan after the listing of "New Third Board", which provided necessary capital supplement for the company's development.

March 17-20

Yinyi Biotech participated in the "Fifteenth China Interventional Cardiology Conference" held at the Beijing National Convention Center.

January 30th

Yinyi Bio-Bio held the 2015 year-end summary and recognition meeting.

January 14-17

Yinyi Biological participated in the "7th Clinical Cardiovascular Disease Conference and the 13th China Coronary Intervention Salon" in Beijing.

2015

December 18th

The company's "New Third Board" was officially listed. The stock abbreviation is "Yinyi Bio", the stock code: 835066.

2014

April

Our company has obtained the 3A certificate of integrity tax payment

2012

Memorabilia

The balloon dilatation catheter was approved by SFDA for marketing

Memorabilia

Polymer-free drug heart stent was approved for marketing in Thailand

Memorabilia

Won the national "Twelfth Five-Year" science and technology support plan project

Memorabilia

Obtained the special plan project of the national old industrial base structure adjustment

Memorabilia

Recognized as Liaoning Provincial Enterprise Technology Center

Memorabilia

Is recognized as a national innovative pilot enterprise

2011

Memorabilia

The coronary metal stent system obtained CE certification

Memorabilia

Balloon dilatation catheter obtained CE certification

Memorabilia

Identified as an enterprise post-doctoral scientific research base in Liaoning Province

Memorabilia

Polymer-free drug heart stent won the first prize of Dalian Technology Invention

2010

Memorabilia

The new version of the quality system passed the annual on-site audit by Beijing National Medical Equipment Huaguang Certification Co., Ltd.

Memorabilia

The one-year follow-up results of the SERY study were announced for the first time at the Great Wall International Cardiology Conference

Memorabilia

Our company was approved as a member of Liaoning Medical Device Industry Association

2009

Memorabilia

Won the Dalian Independent Innovation Product Certificate

Memorabilia

The new pipe net-shaped stent has obtained the national authorized invention patent

2008

Memorabilia

Polymer-free drug-carrying stent obtained national authorized invention patent

Memorabilia

Identified as a national high-tech enterprise

2007

Memorabilia

The first polymer-free drug heart stent in China was approved by SFDA for marketing

2006

Memorabilia

Obtained the National "Eleventh Five-Year" Science and Technology Support Program Project

2005

Memorabilia

Obtained the national high-tech industrialization demonstration project

Memorabilia

Won the National 863 Program Project

2004

Memorabilia

Registered and established a scientific and technological achievement transformation entity-Liaoning Biomedical Materials R&D Center Co., Ltd.

Memorabilia

The coronary metal stent system was approved by SFDA for marketing

Memorabilia

Won the National "Tenth Five-Year Plan" Science and Technology Project

Memorabilia

Won the National Technology Innovation Fund Project for Small and Medium-sized Enterprises

2003

Memorabilia

Liaoning Provincial Biomedical Materials R&D Center was established with the approval of the Liaoning Provincial Department of Science and Technology

Memorabilia

The coronary metal stent is approved by SFDA for marketing